Objectives-Smoke inhalation is a well known cause of airways injury in firefighting personnel. The aim of this study was to evaluate whether toxic effects of smoke on the respiratory tract can be detected by measuring Clara cell protein (CC16), a recently described serum marker of lung function. Methods-CC16 was measured by a sensitive latex immunoassay in the serum of six voluntary firefighters from a chemical plant who had inhaled smoke from the combustion of polypropylene for about 20 minutes. The protein was measured immediately after the fire and 10 days later. The values were compared with those of six control workers examined simultaneously. Results-The mean (SD) concentration of CC16 in the serum of firefighters after the fire (54.4 (34.9) pgol) was significantly higher than that of controls (19-5 (11-7), P = 0.04). 10 days later, serum CC16 from firefighters had returned to the concentrations found in controls (15.9 (2.76) v 17-7 (12-5)). With the values at day 10 as a baseline, the rise of serum CC16 was estimated at 328% on average (range 100°/-564%). These changes were found in the absence of any functional sign of lung impairment. Conclusion-Acute exposure to smoke results in a transient increase of CC16 in serum due most likely to an increased permeability ofthe bronchoalveolar / blood barrier. Serum CC16 seems potentially to be a new biomarker for the early detection of acute airways injury caused by smoke.
higher than that of controls (19-5 (11-7), P = 0.04). 10 days later, serum CC16 from firefighters had returned to the concentrations found in controls (15.9 (2.76) v 17-7 ). With the values at day 10 as a baseline, the rise of serum CC16 was estimated at 328% on average (range 100°/-564%). These changes were found in the absence of any functional sign of lung impairment. Conclusion-Acute exposure to smoke results in a transient increase of CC16 in serum due most likely to an increased permeability ofthe bronchoalveolar / blood barrier. Serum CC16 seems potentially to be a new biomarker for the early detection of acute airways injury caused by smoke. Unit Recently, a new lung biomarker, measurable not only in bronchoalveolar lavage fluid but also in serum has been described.5 This biomarker is a 16 kD microprotein (CC16) secreted by the Clara cells, which are nonciliated epithelial cells predominantly occurring in terminal and respiratory bronchioles. The CC16 has several features which make it a potentially interesting marker of toxicity. It is the major secretary product of a lung cell type that increasingly seems to be an important mediator in the development of lung injury, both as a target cell and as a progenitor cell for regeneration of the epithelium. The exact function of CC16 is still unknown but evidence is accumulating that the protein could protect the respiratory tract by exerting regulatory control over inflammatory reactions and fibroblast chemotaxis. Of special interest for occupational and environmental medicine, CC 16 seems to be the first lung specific biomarker measurable in easily accessible biological media such as serum. Owing to its small size, CC16 secreted into the respiratory tract can indeed readily diffuse into serum where it may serve as a peripheral marker of bronchial cell injury. Although CC 16 is also secreted by the male urogenital tract, the lung seems to be the predominant if not the exclusive source of serum CC16.i6
We report here that serum CC 16 can be used for detecting early changes in the permeability of the bronchoalveolar / capillary barrier caused by smoke or other lung irritants.
Materials and methods

SUBJECTS AND EXPOSURE
The study was carried out on six voluntary firefighters who were members of the first intervention team in a chemical plant. They were aged 27 to 49 years (mean 38-2 years). Three of them were never smokers, two were ex-smokers, and one was a smoker. They were exposed to smoke from the combustion of polypropylene for about 20 (1 19) 1 (94 7% (18-4%) of predicted values). The FEV1/VC ratio averaged 85-6% (4%) and did not differ from that of the pre-employment examination (82-6% (5 6%)) which took place seven to 26 years before.
The concentration of serum CC 16 found in firefighters immediately after the fire was significantly higher than that of controls exam- We checked that these changes were not simply due to diurnal variations by measuring CC1 6 in the serum of seven healthy volunteers collected between 9 00 and 10 00 am, 1 30 and 2 30 pm, and 4 00 and 5 30 pm. The coefficient of variation calculated for each subject ranged from 5-5% to 23-9% (mean 11 -4%). No significant difference was detected by ANOVA between the three sets of means (SDs) (16-7 (5 4), 14-3 (3-7), and 14-5 (3 9) yg/l, respectively).
Discussion
This study shows a transient increase of serum CC16 after a short exposure to smoke. This increase is much too obvious to be ascribable to variations within people. On the basis of our current understanding of CC16 metabolism, the most plausible explanation for this effect is an increased leakage of the protein from its main production site, the respiratory tract. The rapidity of the increase makes the hypothesis of a stimulated production of the protein unlikely but leakage as a transient disruption of the bronchoalveolar / capillary barrier is more likely. Animal studies have shown that bronchial epithelial cell injury caused by smoke is associated with an increased permeability of the bronchoalveolar / capillary barrier to plasma proteins such as albumin.71' If the transcapillary escape of albumin can be enhanced, it can be logically assumed that this should be also the case-but in the opposite direction-for proteins, and especially of CC16 derived from the lung, the passage of which is facilitated by its small size and a huge concentration difference between blood and the fluid of the epithelial lining (more than three orders of magnitude).' This interpretation is supported by the finding of increased concentrations of CC 16 in the serum of patients with lung diseases in whom the integrity of the bronchoalveolar capillary / barrier is compromised-for example, sarcoidosis.5 Other mechanisms that might explain the peak of serum CC16 would be an increased haemoconcentrations or a reduced renal clearance but obviously such mechanisms cannot account for the magnitude of the changes found (up to a fivefold increase); in any case they can be formally ruled out in view of the lack of changes in the serum concentrations of 3,-microglobulin.
Clara cells are very sensitive to lung irritants. It has been shown for instance that the surface structure of Clara cells is very rapidly damaged after exposure to ozone.12 Experimental studies have shown that acute destruction of Clara cells results in reduced production or secretion of CC 16 in the respiratory tract which is mirrored by the serum concentrations. 6 This mechanism has been proposed to explain the reduction of serum CC 16 in cigarette smokers and in workers chronically exposed to crystalline silica."3'4 It is probable that this also occurs after exposure to smoke. This would not be incompatible with the peak of CC 16 reported here which reflects a distinct effect-that is, a disruption of the bronchoalveolar / capillary barrier caused by acute inflammatory changes.
Animal studies show that these two effects can be associated. In rats, for instance, the acute destruction of Clara cells by 4-ipomeanol results in a notable reduction in the concentration of CC 16 in bronchoalveolar lavage fluid and concomitantly in an increase of the protein in serum (Hermans et al, unpublished data). In firefighters, this hypothesis could be tested either by examining basal concentrations of serum CC 16 in regular firefighters or by monitoring serum CC 16 after an episode of acute exposure. By analogy with similar size proteins, the plasma half life of CC 16 can be estimated at a maximum of a few hours. If toxic effects on Clara cells and on the bronchoalveolar / capillary barrier are temporally dissociated, they might give rise to distinct changes in serum.
Whatever the changes of serum CC16 and their underlying mechanism, a consistent feature of the CC 16 response to toxic injury is its higher sensitivity compared with that of classical diagnostic tests. The effects of serum CC16 reported so far were always found in subjects presenting no significant decrement in lung function. Although this sensitivity might increase our capability to detect exposures to chemicals harmful to the respiratory tract, further studies are necessary to establish the importance to health of changes of serum CC16 and the usefulness of this new biomarker for monitoring populations at risk.
